Notice of AGM

Advanced Medical Solutions Grp PLC

17 June 2026

 

17 June 2026

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, will hold its Annual General Meeting ("AGM") at 11.00 a.m. today at the offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP.

The results of the AGM will be announced to the London Stock Exchange and placed on the Group's website, in the usual way, as soon as practicable after the conclusion of the AGM.

Offer period & no new material information

As announced by AMS and H.B. Fuller Company ("H.B. Fuller") respectively on 21 May 2026, on 30 April 2026 AMS received an unsolicited proposal from H.B. Fuller regarding a possible cash offer for the entire issued and to be issued share capital of AMS (the "Possible Offer").

As previously announced, in accordance with Rule 2.6(a) of the Code, H.B. Fuller is required, by no later than 5.00 p.m. (London time) on 18 June 2026, to either announce a firm intention to make an offer for AMS in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

The AMS Board will make no further comment on the Possible Offer at today's AGM, and no other new material information on AMS will be provided.

This announcement is being made without the approval of H.B. Fuller.

- End -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Michael King, Investor Relations
Optimum Strategic Communications	Tel: [phone]
Mary Clark / Nick Bastin / Isabelle Abdou	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Gary Clarence / Harry Hargreaves / Nick Prowting
Berenberg (Joint Broker)	Tel: [phone]
Toby Flaux / Detlir Elezi

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters Surgical, Ifabond, Vitalitec and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made seven acquisitions: Sealantis, an Israeli developer of innovative internal sealants, Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business, Connexicon, an Irish tissue adhesives specialist, Syntacoll, a German specialist in collagen-based absorbable surgical implants and Peters Surgical, a global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices.

AMS's products, manufactured in the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, Austria, France, Poland, Benelux, India, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 1,800 employees. For more information, please see www.admedsol.com.

 

END